Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160252336> ?p ?o ?g. }
- W2160252336 endingPage "770" @default.
- W2160252336 startingPage "762" @default.
- W2160252336 abstract "To compare the efficacy of insulin aspart, a rapid-acting insulin analogue, with that of unmodified human insulin on long-term blood glucose control in Type 1 diabetes mellitus.Prospective, multi-centre, randomized, open-labelled, parallel-group trial lasting 6 months in 88 centres in eight European countries and including 1,070 adult subjects with Type 1 diabetes. Study patients were randomized 2:1 to insulin aspart or unmodified human insulin before main meals, with NPH-insulin as basal insulin. Main outcome measures were blood glucose control as assessed by HbA1c, eight-point self-monitored blood glucose profiles, insulin dose, quality of life, hypoglycaemia, and adverse events.After 6 months, insulin aspart was superior to human insulin with respect to HbA1c with a baseline-adjusted difference in HbA1c of 0.12 (95% confidence interval 0.03-0.22) %Hb, P < 0.02. Eight-point blood glucose profiles showed lower post-prandial glucose levels (mean baseline-adjusted -0.6 to -1.2 mmol/l, P < 0.01) after all main meals, but higher pre-prandial glucose levels before breakfast and dinner (0.7-0.8 mmol/l, P < 0.01) with insulin aspart. Satisfaction with treatment was significantly better in patients treated with insulin aspart (WHO Diabetes Treatment Satisfaction Questionnaire (DTSQ) baseline-adjusted difference 2.3 (1.2-3.3) points, P < 0.001). The relative risk of experiencing a major hypoglycaemic episode with insulin aspart compared to human insulin was 0.83 (0.59-1.18, NS). Major night hypoglycaemic events requiring parenteral treatment were less with insulin aspart (1.3 vs. 3.4% of patients, P < 0.05), as were late post-prandial (4-6 h) events (1.8 vs. 5.0% of patients, P < 0.005).These results show small but useful advantage for the rapid-acting insulin analogue insulin aspart as a tool to improve long-term blood glucose control, hypoglycaemia, and quality of life, in people with Type 1 diabetes mellitus." @default.
- W2160252336 created "2016-06-24" @default.
- W2160252336 creator A5017807280 @default.
- W2160252336 creator A5043396690 @default.
- W2160252336 creator A5087844534 @default.
- W2160252336 date "2000-11-01" @default.
- W2160252336 modified "2023-10-16" @default.
- W2160252336 title "Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial" @default.
- W2160252336 cites W1970065450 @default.
- W2160252336 cites W1978066716 @default.
- W2160252336 cites W2003778247 @default.
- W2160252336 cites W2005300371 @default.
- W2160252336 cites W2021160326 @default.
- W2160252336 cites W2029699674 @default.
- W2160252336 cites W2030768028 @default.
- W2160252336 cites W2041720523 @default.
- W2160252336 cites W2053846593 @default.
- W2160252336 cites W2058804545 @default.
- W2160252336 cites W2062772470 @default.
- W2160252336 cites W2064936958 @default.
- W2160252336 cites W2065443996 @default.
- W2160252336 cites W2072452722 @default.
- W2160252336 cites W2076693232 @default.
- W2160252336 cites W2078195708 @default.
- W2160252336 cites W2081375366 @default.
- W2160252336 cites W2083639055 @default.
- W2160252336 cites W2110177016 @default.
- W2160252336 cites W2163213453 @default.
- W2160252336 cites W2337454357 @default.
- W2160252336 cites W2475536034 @default.
- W2160252336 cites W2769264260 @default.
- W2160252336 cites W4234329496 @default.
- W2160252336 cites W4249094504 @default.
- W2160252336 cites W964503500 @default.
- W2160252336 doi "https://doi.org/10.1046/j.1464-5491.2000.00380.x" @default.
- W2160252336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11131100" @default.
- W2160252336 hasPublicationYear "2000" @default.
- W2160252336 type Work @default.
- W2160252336 sameAs 2160252336 @default.
- W2160252336 citedByCount "221" @default.
- W2160252336 countsByYear W21602523362012 @default.
- W2160252336 countsByYear W21602523362013 @default.
- W2160252336 countsByYear W21602523362014 @default.
- W2160252336 countsByYear W21602523362015 @default.
- W2160252336 countsByYear W21602523362016 @default.
- W2160252336 countsByYear W21602523362017 @default.
- W2160252336 countsByYear W21602523362018 @default.
- W2160252336 countsByYear W21602523362019 @default.
- W2160252336 countsByYear W21602523362020 @default.
- W2160252336 countsByYear W21602523362021 @default.
- W2160252336 countsByYear W21602523362022 @default.
- W2160252336 crossrefType "journal-article" @default.
- W2160252336 hasAuthorship W2160252336A5017807280 @default.
- W2160252336 hasAuthorship W2160252336A5043396690 @default.
- W2160252336 hasAuthorship W2160252336A5087844534 @default.
- W2160252336 hasConcept C126322002 @default.
- W2160252336 hasConcept C134018914 @default.
- W2160252336 hasConcept C168563851 @default.
- W2160252336 hasConcept C2777180221 @default.
- W2160252336 hasConcept C2778024521 @default.
- W2160252336 hasConcept C2778804033 @default.
- W2160252336 hasConcept C2779306644 @default.
- W2160252336 hasConcept C2779908123 @default.
- W2160252336 hasConcept C2779920387 @default.
- W2160252336 hasConcept C2780668416 @default.
- W2160252336 hasConcept C2781232474 @default.
- W2160252336 hasConcept C2910068830 @default.
- W2160252336 hasConcept C555293320 @default.
- W2160252336 hasConcept C71924100 @default.
- W2160252336 hasConceptScore W2160252336C126322002 @default.
- W2160252336 hasConceptScore W2160252336C134018914 @default.
- W2160252336 hasConceptScore W2160252336C168563851 @default.
- W2160252336 hasConceptScore W2160252336C2777180221 @default.
- W2160252336 hasConceptScore W2160252336C2778024521 @default.
- W2160252336 hasConceptScore W2160252336C2778804033 @default.
- W2160252336 hasConceptScore W2160252336C2779306644 @default.
- W2160252336 hasConceptScore W2160252336C2779908123 @default.
- W2160252336 hasConceptScore W2160252336C2779920387 @default.
- W2160252336 hasConceptScore W2160252336C2780668416 @default.
- W2160252336 hasConceptScore W2160252336C2781232474 @default.
- W2160252336 hasConceptScore W2160252336C2910068830 @default.
- W2160252336 hasConceptScore W2160252336C555293320 @default.
- W2160252336 hasConceptScore W2160252336C71924100 @default.
- W2160252336 hasIssue "11" @default.
- W2160252336 hasLocation W21602523361 @default.
- W2160252336 hasLocation W21602523362 @default.
- W2160252336 hasOpenAccess W2160252336 @default.
- W2160252336 hasPrimaryLocation W21602523361 @default.
- W2160252336 hasRelatedWork W1964974772 @default.
- W2160252336 hasRelatedWork W1966225706 @default.
- W2160252336 hasRelatedWork W2016328345 @default.
- W2160252336 hasRelatedWork W2042819106 @default.
- W2160252336 hasRelatedWork W2048226041 @default.
- W2160252336 hasRelatedWork W2066345847 @default.
- W2160252336 hasRelatedWork W2068166803 @default.
- W2160252336 hasRelatedWork W2166209517 @default.
- W2160252336 hasRelatedWork W2171960002 @default.
- W2160252336 hasRelatedWork W2430205611 @default.